“Conversion Therapy for Advanced Hepatocellular Carcinoma Following Complete Response to Transarterial Radioembolization Combined With Atezolizumab and Bevacizumab”. Radiology and Oncology 60, no. 1 (March 26, 2026): 40–48. Accessed July 30, 2026. https://www.ojstest.computing.si/index.php/ro/article/view/4783.